Understanding and preventing drug-resistant infections in nursing homes
MDRO Carriage, Transmission, Sequelae, and Prevention in Nursing Homes
This study is looking into how infections from germs that don't respond to many medicines are spreading in nursing homes, and it's designed to help keep residents healthier by finding better ways to prevent these infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11118995 on NIH RePORTER |
What this research studies
This research investigates the growing issue of multidrug-resistant organisms (MDROs) in nursing homes, where a significant percentage of residents are affected. The project aims to identify how these infections spread and develop effective prevention strategies. By combining expertise from various fields, the research will analyze data from nursing home residents and their environments to understand the sources of these infections better. Patients may be involved in studies that assess the impact of these organisms on their health and the effectiveness of new interventions.
Who could benefit from this research
Good fit: Ideal candidates for participation include residents of nursing homes who may be affected by multidrug-resistant infections.
Not a fit: Patients who are not residing in nursing homes or who do not have any risk factors for multidrug-resistant infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and management of drug-resistant infections in nursing homes, enhancing patient safety and health outcomes.
How similar studies have performed: Previous research has shown success in addressing similar issues of infection control in healthcare settings, indicating that this approach has potential for impactful results.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Huang, Susan S. — University of California-Irvine
- Study coordinator: Huang, Susan S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.